REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/04/2025
Back to search
Official data from USPTO
HEALTH NUCLEUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
02/04/2025
Classification
Registered
Trademark type
Combined
Nice classes
42, 44
Filing date
12/28/2015
Registration date
02/04/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2020
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/31/2015
First use in commerce
10/12/2015
Drawing code
3
Owner type
16
Owner location
SAN DIEGO, CA
Examiner
GILBERT, HANNAH
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "HEALTH NUCLEUS" in stylized font with a solid circle in the center of the "C".
Holders and representatives
Holders
HLI Nucleus Holdings, LLC
HLI Nucleus Holdings, LLC
Representatives
Anna King Banner & Witcoff, Ltd.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
scientific research services in the field of genomics and advanced clinical imaging to be used for personalized health; research and development in the field of genome sequencing and genome analysis; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencinggenomic and microbiome analysisgenetic testing and screening for research purposesmetabolomics dataphenotyping datamolecular analyticspatient scientific and medical informationgenealogical informationhealth risk assessmentpreparing related information reports therefor; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencinggenomic and microbiome analysisgenetic testing and screening for research purposesmetabolomics dataphenotyping datamolecular analyticspatient scientific and medical informationgenealogical informationhealth risk assessment from information obtained through advanced clinical imagingultrasound imagingmagnetic resonance imaging (MRI)X-rayradiographycomputed tomography (CT)fluoroscopypositron emission tomographymammographyechocardiogram servicespreparing related information reports therefor; providing online searchable databases in the fields of genomic and microbiome sequencinggenomic and microbiome analysisgenetic testing and screening for research purposesmetabolomics dataphenotypingmolecular analyticspatient scientific and medical informationgenealogical informationadvanced clinical imaginghealth risk assessment for scientific research purposes; application service provider (ASP) featuring software for use in data managementdata storagedata analysisreport generationall in the fields of genomic and microbiome sequencinggenomic and microbiome analysisgenetic testing and screening for research purposeshealth risk assessment; scientific research in the fields of genomicsgeneticsgenetic testinggenetic screeninggenotypingphenotypingmolecular analyticshealth risk assessmentgenealogical information; scientific research in the fields of genomicsgeneticsgenetic testinggenetic screeninggenotypingphenotypingmolecular analyticshealth risk assessment from information obtained through advanced clinical imagingultrasound imagingmagnetic resonance imaging (MRI)X-rayradiographycomputed tomography (CT)fluoroscopypositron emission tomographymammographyechocardiogram servicesgenealogical information; medical research; scientific investigations for medical purposes; medical and scientific research in the field of medical imaging; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research in the field of genome sequence analysis and genome sequence reporting for research purposesmicrobiome sequencingmetabolome analysisadvanced clinical imaginglaboratory testshealth risk assessmentmedical imaging and DNA screening; research and development in the field of genome sequence analysis and genome sequence reportingmicrobiome sequencingmetabolome analysisadvanced clinical imaginglaboratory testshealth risk assessmentmedical imaging and DNA screening; scientific research for medical purposes in the field of genome sequence analysis and genome sequence reportingmicrobiome sequencingmetabolome analysisadvanced clinical imaginglaboratory testshealth risk assessmentmedical imaging and DNA screening; genetic testing of humans for scientific research purposes; all for scientific research purposes
Class 44
genetic testing of humans for medical diagnostic purposes; consulting services in the fields of diagnostic medical testing; DNA screening for medical purposes; genetic counseling; medical assistance consultancy provided by doctors and other specialized medical personnel; medical assistance consultancy provided by genomics and genetics experts; medical assistance services in the nature of genetic and medical information provided to medical professionals from remote locations via the internet and global computer networks through the use of archived genome sequence informationmedical imagesdiagnostic test resultsa data storage and retrieval system; medical genetic testing consultations provided via phoneonline chat or videoconferencing; medical diagnostic testingmonitoring and reporting services; medical imaging services; medical information; medical screening; medical testing for diagnostic purposes; medical testing of bloodsalivastool; multi-disciplinaryintegrativegenetic consultations for medical treatment purposes; providing a web site featuring genetic and medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processedexchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing medical information; providing medical informationconsultancy and advisory services; providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptomsconcernsgenome sequencing analysismicrobiome sequencing analysismetabolome analysisadvanced clinical imaginglaboratory testsmedical imaging and DNA screening; providing medical testing and medical consultations to individuals and their physicians to help them make healthwellness and nutritional changes in their daily living to improve health; providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms based on genome sequencing analysismicrobiome sequencing analysismetabolome analysisadvanced clinical imaginglaboratory testsmedical imaging and DNA screening; provision of health care and medical services by health care professionals via the internet or telecommunication networks; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; health assessment servicesproviding assessment of risk of disease and providing health monitoring of individuals all through use of genome sequencing analysis and reportingmicrobiome sequencing analysismetabolome analysisadvanced clinical imaginglaboratory testsmedical imaging and DNA screening; all for medical treatment and diagnostic purposes
Publications
History of USPTO decisions and trademark events.
51 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/18/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/18/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/18/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/18/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/18/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2019
PUBO
PUBLISHED FOR OPPOSITION
11/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/30/2019
EXPT
EXPARTE APPEAL TERMINATED
10/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/03/2019
RBFT
REPLY BRIEF FILED - CHECK TTAB FILES
09/04/2019
GNSN
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
08/13/2019
GNES
EXAMINERS STATEMENT E-MAILED
08/13/2019
CNES
EXAMINERS STATEMENT - COMPLETED
08/13/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/23/2019
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
07/18/2019
GECD
ACTION DENYING REQ FOR RECON E-MAILED
07/18/2019
CNCF
ACTION CONTINUING FINAL - COMPLETED
07/18/2019
DOCK
ASSIGNED TO EXAMINER
06/20/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/12/2019
EXPI
EX PARTE APPEAL-INSTITUTED
06/12/2018
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
06/12/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/13/2017
GNFR
FINAL REFUSAL E-MAILED
12/13/2017
CNFR
FINAL REFUSAL WRITTEN
12/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2017
GNRT
NON-FINAL ACTION E-MAILED
05/19/2017
CNRT
NON-FINAL ACTION WRITTEN
05/19/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/09/2017
ALIE
ASSIGNED TO LIE
05/09/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/01/2016
GNSL
LETTER OF SUSPENSION E-MAILED
11/01/2016
CNSL
SUSPENSION LETTER WRITTEN
11/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/19/2016
GNRT
NON-FINAL ACTION E-MAILED
04/19/2016
CNRT
NON-FINAL ACTION WRITTEN
04/19/2016
DOCK
ASSIGNED TO EXAMINER
04/12/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2016
NWAP
NEW APPLICATION ENTERED
12/31/2015
Continuous trademark protection
Get notified about every new filing that threatens HEALTH NUCLEUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.